Kuwait Direct Investment Promotion Authority (KDIPA) participated in the inauguration of Johnson and Johnson Healthcare Office, KDIPA licensed company, on May 21st 2024, at Burj AlShaya.
The inauguration ceremony opened with speeches by Mr. Pedro Matos Rosa, General Manager of Johnson and Johnson Innovative Medicines, H.E. Karen Sasahara, US Ambassador to the State of Kuwait, and Mr. Loai Abu El-Hawa, General Manager of Gulf & Levant DPS Business Unit Senior Director MEA J&J MedTech, Sheikh Abdullah Sabah Al-Sabah, Assistant Director General for Investment Operations. High-ranking officials and leaders were in attendance for the inauguration of the Johnson and Johnson Healthcare Office, which was established with the support of KDIPA.
The establishment of the Johnson and Johnson Healthcare office in Kuwait is a strategic move, underlying Johnson and Johnson’s unwavering commitment to supporting Kuwait’s development and fostering a more direct and impactful relationship with the community.
KDIPA was represented by Mr. Mohammed Al-Sabbagh, Director of Audit & Follow-Up Department, and Mrs. Nouf Al-Muzayyan, Head of Investment Projects Follow Up Section.
